Evidence map›Paper›PMID 26110264›Full record

ArticlePloS one2015

Cationic Cell-Penetrating Peptides Are Potent Furin Inhibitors.

Bruno Ramos-Molina, Adam N Lick, Amir Nasrolahi Shirazi, Donghoon Oh, Rakesh Tiwari, Naglaa Salem El-Sayed, Keykavous Parang, Iris Lindberg

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Development and Prospects of Furin Inhibitors for Therapeutic Applications.International journal of molecular sciences · 2024
    Review
  4. Article
  5. Article
  6. Cell-Penetrating Peptides.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Bruno Ramos-MolinaDepartment of Anatomy and Neurobiology, School of Medicine, University of Maryland-Baltimore, Baltimore, Maryland, United States of America.
Adam N LickDepartment of Anatomy and Neurobiology, School of Medicine, University of Maryland-Baltimore, Baltimore, Maryland, United States of America.
Amir Nasrolahi ShiraziChapman University, School of Pharmacy, Irvine, California, United States of America.
Donghoon OhChapman University, School of Pharmacy, Irvine, California, United States of America.
Rakesh TiwariChapman University, School of Pharmacy, Irvine, California, United States of America.
Naglaa Salem El-SayedChapman University, School of Pharmacy, Irvine, California, United States of America.
Keykavous ParangChapman University, School of Pharmacy, Irvine, California, United States of America.
Iris LindbergDepartment of Anatomy and Neurobiology, School of Medicine, University of Maryland-Baltimore, Baltimore, Maryland, United States of America.
Chapman University · USUniversity of Maryland, Baltimore · US

Funding

OPIOID PEPTIDE SYNTHESIZING ENZYMESR01DA005084 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI LINDBERG, IRIS · 1988 to 2014
$4.4M
Opioid Peptide Synthesizing EnzymesR56DA005084 · NIDA · UNIVERSITY OF MARYLAND BALTIMORE · PI LINDBERG, IRIS · 2016 to 2016
$174k
NIDA NIH HHS R01 DA005084NIDA NIH HHS R01 DA05084-27NIDA NIH HHS R56 DA005084
6 · The paper itself

Abstract

Cationic cell-penetrating peptides have been widely used to enhance the intracellular delivery of various types of cargoes, such as drugs and proteins. These reagents are chemically similar to the multi-basic peptides that are known to be potent proprotein convertase inhibitors. Here, we report that both HIV-1 TAT47-57 peptide and the Chariot reagent are micromolar inhibitors of furin activity in vitro. In agreement, HIV-1 TAT47-57 reduced HT1080 cell migration, thought to be mediated by proprotein convertases, by 25%. In addition, cyclic polyarginine peptides containing hydrophobic moieties which have been previously used as transfection reagents also exhibited potent furin inhibition in vitro and also inhibited intracellular convertases. Our finding that cationic cell-penetrating peptides exert potent effects on cellular convertase activity should be taken into account when biological effects are assessed.

Indexed as

Antimicrobial Cationic PeptidesCell Line, TumorCell MovementCell-Penetrating PeptidesCysteamineFurinHIV-1HumansPeptide FragmentsPeptidestat Gene Products, Human Immunodeficiency VirusAntimicrobial Cationic PeptidesCell-Penetrating PeptidesCysteamineFurinPep-1 peptidePeptide FragmentsPeptidestat Gene Products, Human Immunodeficiency Virustat peptide (47-57), Human immunodeficiency virus 1

Identifiers

PMID26110264
PMCPMC4482483
OpenAlexW800360063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.